Leg ischemia: Assessment with MR angiography and spectroscopy

Radiology

Volumn 234, Issue 3, 2005, Pages 833-841

  Baumgartner, Iris ^a   Thoeny, Harriet C ^b   Kummer, Oliver ^a   Roefke, Christian ^b   Skjelsvik, Corinna ^a   Boesch, Chris ^c   Kreis, Roland ^c  

^a Kantonsspital Frauenfeld   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYMYOGLOBIN; MYOGLOBIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLATERAL CIRCULATION; DISEASE COURSE; EXERCISE; FEMALE; FOLLOW UP; GENE THERAPY; HUMAN; LEG ISCHEMIA; LIMB PERFUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESSURE; PRIORITY JOURNAL; REPRODUCIBILITY;

AGED; ANGIOPLASTY; COLLATERAL CIRCULATION; CONTRAST MEDIA; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; GENE THERAPY; HUMANS; ISCHEMIA; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOGLOBIN; OBSERVER VARIATION; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 13844256804     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2343031440     Document Type: Article

References (37)

1. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97:1114-1123.
2. Comerota AJ, Throm RC, Miller K, et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 2002; 35:930-936.
3. Shyu KG, Chang H, Wang BW, Kuan P. Intramuscular vascular endothelial growth factor (VEGF165) gene therapy in Chinese patients with chronic critical leg ischemia. Am J Med 2003; 114:85-92.
4. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002; 360:427-435.
5. Isner JM. Therapeutic angiogenesis: a new frontier for vascular therapy. Vasc Med 1996; 1:79-87.
6. Takeshita S, Rossow ST, Kearney M, et al. Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995; 147:1649-1660.
7. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80:829-837.
8. Peterkin GA, Manabe S, La Morte WW, Menzoian JO. Evaluation of a proposed standard reporting system for preoperative angiograms in infrainguinal bypass procedures: angiographic correlates of measured runoff resistance. J Vasc Surg 1988; 7:379-385.
9. Karacagil S, Alingren B, Bowald S, Eriksson I. Angiographic runoff patterns in patients undergoing lower limb revascularization. Acta Chir Scand 1989; 155:19-24.
10. Vosshenrich R, Kopka L, Castillo E, Böttcher U, Graessner J, Grabbe E. Electrocardiograph-triggered two-dimensional time-of flight versus optimized contrast-enhanced three-dimensional MR angiography of the peripheral arteries. Magn Reson Imaging 1998; 16:887-892.
11. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000; 217:105-114.
12. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta analysis. JAMA 2001; 285:1338-1345.
13. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995; 1:1085-1089.
14. Pena CS, McCauley TR, Price TB, Sumpio B, Gusberg RJ, Gore JC. Quantitative blood flow measurements with cine-phase-contrast MR imaging of subjects at rest and after exercise to assess peripheral vascular disease. AJR Am J Roentgenol 1996; 167:153-157.
15. Frank LR, Wong EC, Haseler LJ, Buxton RB. Dynamic imaging of perfusion in human skeletal muscle during exercise with arterial spin labeling. Magn Reson Med 1999; 42:258-267.
16. Molé PA, Chung Y, Tran TK, Sailasuta N, Hurd R, Jue T. Myoglobin desaturation with exercise intensity in human gastrocnemius muscle. Am J Physiol 1999; 277(pt 2):R173-R180.
17. Wang Z, Noyszewski EA, Leigh JS. In vivo MRS measurement of deoxymyoglobin in human forearms. Magn Reson Med 1990; 14:562-567.
18. Brillault-Salvat C, Giacomini E, Jouvensal L, Wary C, Bloch G, Carlier PG. Simultaneous determination of muscle perfusion and oxygenation by interleaved NMR plethysmography and deoxymyoglobin spectroscopy. NMR Biomed 1997; 10:315-323.
19. Kreis R, Bruegger K, Skjelsvik C, et al. Quantitative 1H magnetic resonance spectroscopy of myoglobin de- and re-oxygenation in skeletal muscle: reproducibility and effects of location and disease. Magn Reson Med 2001; 46:240-248.
20. European Working Group on Critical Leg Ischemia. Second European consensus document on chronic critical leg ischemia. Circulation 1991; 84(suppl 4):IV1-IV26.
21. Witzenbichler B, Asahara T, Murohara M, et al. Post-natal overexpression of vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998; 153:381-394.
22. Isner JM, Rosenfield K. Redefining the treatment of peripheral artery disease: role of percutaneous revascularization. Circulation 1993; 88:1534-1557.
23. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. Guidelines for percutaneous transluminal angioplasty. J Vasc Interv Radiol 1990; 1:5-13.
24. Gartenmann Ch, Kirchberger I, Herzig M, et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease: evaluation of a pilot project. Vasa 2002; 31:29-34.
25. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial occlusive disease. Circulation 1990; 81:602-609.
26. Fleiss JL, Everitt BS. Comparing the marginal totals of square contingency tables. Br J Math Stat Psychol 1971; 24:117-123.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical management. Lancet 1986; 1:307-310.
28. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517-538.
29. Schaper W, de Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971; 28:671-679.
30. Pasyk S, Schaper W, Schaper J, Pasky K, Miskiewicz G, Steinseifer B. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol 1982; 242:H1031-H1037.
31. Kemp GJ, Radda GK. Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q 1994; 10:43-63.
32. Argov Z, Lofberg M, Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance. Muscle Nerve 2000; 23:1316-1334.
33. Hands LJ, Sharif MH, Payne GS, Morris PJ, Radda GK. Muscle ischaemia in peripheral vascular disease studied by 31P-magnetic resonance spectroscopy. Eur J Vasc Surg 1990; 4:637-642.
34. Mancini DM, Wilson JR, Bolinger L, et al. In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with heart failure: demonstration of abnormal muscle metabolism despite adequate oxygenation. Circulation 1994; 90:500-508.
35. Rutherford RB. Vascular surgery. 4th ed. Philadelphia, Pa: Saunders, 1995.
36. Ramsey DE, Manke DA, Sumner DS. Toe blood pressure: a valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg (Torino) 1983; 24:43-48.
37. Kummer O, Widmer MK, Pluss S, et al. Does infection affect amputation rate in chronic critical leg ischemia? Vasa 2003; 32:18-21.